News FocusMicrobiology

Training a Molecular Gun on Killer E. coli

Science  20 Nov 1998:
Vol. 282, Issue 5393, pp. 1404
DOI: 10.1126/science.282.5393.1404

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Researchers at the National Institutes of Health are closing in on the development of the first vaccine against Escherichia coli O157:H7, a pathogenic version of the common gut bacterium. Tests of an experimental vaccine showed promise in adults earlier this year, and the researchers are about to apply for approval to test it in young children. If the trial gets the go-ahead and the preparation passes further tests, experts say, a vaccine for people and one for livestock could be available early next century.

Related Content